Tag: LDAA therapy

Azathioprine and Allopurinol: How Low-Dose Combination Therapy Prevents Toxic Metabolite Buildup
5, December, 2025

Azathioprine and Allopurinol: How Low-Dose Combination Therapy Prevents Toxic Metabolite Buildup

Azathioprine and allopurinol together can prevent toxic metabolite buildup in patients with autoimmune diseases. This low-dose combo redirects metabolism to boost therapeutic effects and reduce liver damage-when properly monitored.

Read more